Clinical Trial Update: Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating irinotecan with fluorouracil and leucovorin in patients with advanced gastrointestinal cancers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Carcinoma of the Appendix

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Mayo Clinic | Conditions: Anal Cancer, Carcinoma of the Appendix | Phase 1 | Status: COMPLETED